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The hepatitis C virus (HCV) nonstructural protein 3 (NS3) is a
multifunctional enzyme with serine protease and DEXH/D-box
helicase domains. A crystal structure of the NS3 helicase domain
(NS3h) was generated in the presence of a single-stranded oligonu-
cleotide long enough to accommodate binding of two molecules of
enzyme. Several amino acid residues at the interface of the two
NS3h molecules were identified that appear to mediate a protein-
protein interaction between domains 2 and 3 of adjacentmolecules.
Mutations were introduced into domain 3 to disrupt the putative
interface and subsequently examined using an HCV subgenomic
replicon, resulting in significant reduction in replication capacity.
Themutations in domain 3 were then examined using recombinant
NS3h in biochemical assays. The mutant enzyme showed RNA
binding and RNA-stimulated ATPase activity that mirrored wild
type NS3h. In DNA unwinding assays under single turnover condi-
tions, themutant NS3h exhibited a similar unwinding rate and only
2-fold lower processivity than wild type NS3h. Overall biochemi-
cal activities of the mutant NS3h were similar to the wild type
enzyme, which was not reflective of the large reduction in HCV
replicative capacity observed in the biological experiment. Hence,
the biological results suggest that the known biochemical proper-
ties associated with the helicase activity of NS3h do not reveal all of
the likely biological roles of NS3 duringHCV replication. Domain 3
of NS3 is implicated in protein-protein interactions that are neces-
sary for HCV replication.
Hepatitis C virus (HCV),5 a member of the family Flaviviridae, is a
leading cause of liver cirrhosis and hepatocellular carcinoma and has
infectedmore than 170million people worldwide (1–3). Standard treat-
ment with interferon- and ribavirin is frequently ineffective or toxic,
and no vaccine for HCV is currently available (4). Identification of a
novel viral target for therapeutic intervention could lead to the devel-
opment of a more effective treatment.
TheHCV genome is a 9.6-kb positive, single-stranded RNA that sup-
ports translation of a 3000-amino acid polyprotein, which is subse-
quently cleaved to produce both structural (C, E1, and E2) and non-
structural (NS2, NS3, NS4A, NS4B, NS5A, andNS5B) viral proteins (5).
Two viral proteases are encoded by the NS2 and NS3 genes (6, 7). In
addition to its protease domain, the NS3 protein also contains a DEXH/
D-box helicase domain (8). NS4A encodes a peptide co-factor for NS3
protease (9), and NS5B encodes an RNA-dependent RNA polymerase
(10). The functions of NS4B and NS5A have not been as well character-
ized, but NS5A is involved in viral interferon sensitivity (11) and in
adaptation of subgenomic replicons for growth in cultured hepatoma
cells (12).
One obstacle to studying viral protein interactions is that HCV can-
not be maintained efficiently in cell culture, although recent progress
may overcome this difficulty (13). In order to circumvent this problem,
selectable replicons carrying the neomycin phosphotransferase gene in
addition to essential HCV genes and untranslated flanking regions have
been constructed (14). Viral genes are translated independently of the
neomycin phosphotransferase gene from an encephalomyocarditis
virus internal ribosome entry site. Replication in cell culture has been
further enhanced by the introduction of adaptive mutations primarily
within the NS5A gene (12), although the specific mechanism by which
thesemutations influence replication is not known. These adaptive rep-
licon mutants provide a means of studying HCV replication in cultured
cells.
Many aspects of the HCV replication mechanism remain unknown,
but it appears that at least five of the viral nonstructural proteins are
required for replication (5). Several nonstructural protein-protein inter-
actions have been identified (15, 16), and co-localization of nonstruc-
tural proteins, including NS3 and NS5B, on membrane structures
within cells has been observed (17, 18), indicating formation of a mul-
tiprotein replication complex containing both polymerase and helicase
enzymes. Understanding the mechanism of nucleic acid unwinding by
NS3 is therefore a key step in characterizing the viral replication
mechanism.
Helicases are molecular motor proteins that utilize energy from ATP
hydrolysis to manipulate nucleic acids as well as protein-nucleic acid
complexes (19–21). NS3 helicase (NS3h) has been expressed and puri-
fied independently of NS3 protease in a recombinant bacterial system
and retains its in vitro unwinding activity (8). The NS3h structure con-
sists of three distinct domains, with domains 1 and 2 containing all of the
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conserved motifs common to superfamily II helicase enzymes (22, 23).
ATP binds at the interface between domains 1 and 2, and nucleic acid
binds within a cleft formed at the interface between domain 3 and
domains 1 and 2 (23). Interactions between the protein and nucleic acid
are not sequence-specific and primarily involve the phosphate back-
bone of the nucleic acid.
Despite extensive structural and biochemical characterization, the
oligomeric state of the functional species of NS3 has not been deter-
mined conclusively. Biochemical studies have resulted in reports of
monomeric (24), dimeric (25, 26), and oligomeric (27, 28) forms of the
protein. Crystal structures of NS3h (22), NS3h bound to an 8-mer
poly(dU) substrate (23), and a full-lengthNS3/NS4A fusion protein (29)
demonstrate that a single proteinmonomer can form crystals. However,
none of these structures includes a substrate molecule of sufficient
length to accommodate binding of multiple NS3h monomers. Cross-
linking experiments indicate that NS3h can form oligomeric structures
in solution (28). DNAunwinding activity of full-lengthNS3 is optimal at
concentrations high enough to allow binding of multiple NS3h mono-
mers to each nucleic acidmolecule (30). However, no cooperative effect
has been observed in binding studies (31), leaving open the possibility
that NS3 is a nonprocessivemonomer. A recently reported biochemical
model suggests that monomeric NS3h is functional but that multiple
NS3h molecules are required for optimal processivity (32).
We have crystallized NS3h bound to a 16-mer poly-dU nucleic acid.
The structure shows two NS3h molecules bound to a single DNAmol-
ecule and reveals an apparent interface between the two protein mole-
cules. A mutational analysis of the protein interface region was per-
formed in order to determine its importance for helicase activity and
viral replication.
EXPERIMENTAL PROCEDURES
Purification of NS3h—BL21(DE3) cells were co-transformed with
pET26b expression plasmid containing a wild type or mutant NS3h
gene with an NH2-terminal ubiquitin tag and pCG1 expressing the
ubiquitin protease Ubp1. 3.5 liters of transformed cells were cultured at
37 °C to anA600 of 1.5 inNZCYMbroth containing 30g/ml kanamycin
and 30 g/ml chloramphenicol. Overexpression was induced by the
addition of 3.5 liters of chilled NZCYM, 0.2% dextrose, and 0.5 mM
isopropyl 1-thio--D-galactopyranoside. Antibiotic concentrations
were kept constant. Cells were cultured at 15 °C for 16–18 h following
induction. All subsequent steps were performed at 4 °C. NS3h purifica-
tionwas followed bymeasuring poly(U)-dependentATPase activity and
by SDS-PAGE. Cells were centrifuged at 6000 rpm for 10 min in a
Beckman JLA-10.500 rotor and resuspended in lysis buffer (25mMTris/
Cl, pH 7.5, 1 mM EDTA, 500 mM NaCl, 5 mM -mercaptoethanol, 10%
glycerol) at 5 ml/g. Cells were lysed by the addition of 4 mM phenyl-
methylsulfonyl fluoride, 4g/ml pepstatinA, and 2.25mgof lysozyme/g
of cells, followed by a freeze/thaw in liquid nitrogen, pressurization at
1500 p.s.i. for 3 min in a nitrogen bomb, and sonication. The lysate was
centrifuged at 20,000 rpm for 20 min in a Beckman JA-25.50 rotor. The
supernatant was further centrifuged at 45,000 rpm for 2 h in a Beckman
50.2 Ti rotor. The supernatant from the final centrifugation was further
purified by anion exchange chromatography. NS3h was eluted in the
wash from the anion exchange columnwith lysis buffer and precipitated
by the addition of 55% (NH4)2SO4 followed by centrifugation at 20,000
rpm for 60 min in a Beckman JA-25.50 rotor. Pellets were resuspended
in lysis buffer plus 500 mM (NH4)2SO4. NS3h was further purified using
methyl-hydrophobic (30 ml), heparin-Sepharose (30 ml), and poly(U)
affinity (20 ml) chromatography columns. NS3h was eluted from each
column with a low salt/high salt buffer gradient (10 mM/1 M NaCl in 25
mM Tris/Cl, pH 7.5, 1 mM EDTA, 5 mM -mercaptoethanol, 10% glyc-
erol). The gradient was reversed for the hydrophobic column. NS3h
eluted from the hydrophobic and heparin-Sepharose columns between
250 and 450 mM NaCl and from the poly(U) column between 450 and
650 mM NaCl. Fractions containing NS3h were combined and dialyzed
into low salt buffer following elution from each column. Fractions from
the final column were dialyzed into storage buffer (25 mM Tris/Cl, pH
7.5, 1mMEDTA, 100mMNaCl, 5mM -mercaptoethanol, 20% glycerol)
and concentrated to 7–10 M.
Crystallization and Structural Determination of NS3h—Purified
NS3h was concentrated to 32.2 mg/ml for crystallization. Examination
of sample purity and determination of molecular weight were per-
formed using SDS-PAGE on a Phast Gel system (AP Biotech). The
apparent molecular mass of the helicase was 50 kDa. The (dU)16 oli-
gonucleotide was synthesized using an Expedite nucleic acid synthesis
system and purified by polyacrylamide gel electrophoresis to a final
concentration of 4.6 mg/ml. Immediately before crystallization, NS3h
was mixed with the (dU)16 oligonucleotide at a 2:1 molar ratio. Crystals
of diffraction quality were obtained by using the hanging drop method
at room temperature with 4 l of the mixture and 1 l of reservoir
solution (2.4 M (NH4)2SO4, 0.1 M Tris hydrochloride, pH 8.5). Diffrac-
tion data were collected at 1.5418 Å by using a single crystal of 0.2 
0.4  0.1 mmmounted in a thin-walled glass capillary at room temper-
ature. The x-ray radiation was produced by an in-house Rigaku
RU-H3RHB generator and focused by Osmic’s Gutmanmultilayer mir-
rors (Woodland, TX). The diffraction pattern was recorded on the
R-AXIS IV phosphor image plate detector. The diffraction data were
reduced, integrated, and scaled with Denzo/Scalepack. Molecular
replacement analysis was performed using AMORE software (33), and
structure refinements and model building/adjustment were done using
CNS (34) and XtalView (35), respectively.
The scaled data of resolution 3.3 Å indicated that the NS3h/(dU)16
crystal belongs to the orthorhombic space group (Table 1). Space group
assignment between P21212 and P212121 could not be made due to the
absence of some (00l) reflections. Matthews’ coefficient suggested that
the number of proteinmolecules in one asymmetric unit could be 3 or 4,
with solvent content being 67 or 50%, respectively.
We completed the structure determination by molecular replace-
ment (MR), using the published 1A1V structure (23) as an initial model.
The 1A1V structure consists of an NS3h monomer bound to a (dU)8
oligonucleotide. Prior toMR, the oligonucleotidewas removed from the
model. The MR results from space group P21212 did not display any
reasonable correlation among the individual solutions; however, the
MR solutions in space group P212121 showed strong correlation as well
as realistic crystal packing (not shown).
A composite omit map was calculated using CNS (34) to identify any
missing components. The resulting electron density map showed
clearly the presence of the oligonucleotide at the nucleic acid binding
sites of the protein molecules. The (dU)x fragments were inserted man-
ually into the structure using XtalView (35). The maximum likelihood
from structure factors refinement on themodel was done in CNS and is
presented in Table 1.
Construction ofMutant Plasmids—Mutationswere introduced into a
pUC18-NS3 subclone containing nucleotides 1182–4918 from the
HCV-neo-I377/NS3–3-untranslated region replicon sequence (Gen-
BankTM accession number AJ242652) using the QuikChange site-di-
rectedmutagenesis kit (Stratagene).Mutant plasmidswere transformed
into SURE cells and purified from cultured cells with the QIAprep Spin
Miniprep Kit (Qiagen). Mutant subcloned HCV sequences were then
transferred into the replicon plasmid by digestion at PmeI and MluI
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restriction sites followed by ligation.MutantNS3 sequences were trans-
ferred to pET26b-ubiquitin expression plasmid by PCR followed by
digestion at SacII and EcoRI restriction sites and ligation. Quality of all
final plasmid products was confirmed by sequencing.
Replicon RNA Synthesis—DNA template was prepared by digestion
of replicon plasmid (10 g) with ScaI restriction endonuclease at 37 °C
for 4 h. Complete linearization of plasmid was confirmed by agarose gel
electrophoresis. RNA was synthesized in vitro by incubating 0.5 g of
linear DNA template with 0.5 g of T7 RNA polymerase in 350 mM
HEPES, pH 7.5, 32 mMmagnesium acetate, 40 mM dithiothreitol, 2 mM
spermidine, and 28 mM NTPs at 37 °C for 3 h. Template DNA was
removed by incubation with 2 units of DNase I at 37 °C for 30min. RNA
was precipitated overnight in LiCl at 20 °C. RNA purity and quality
were verified by agarose gel electrophoresis.
Colony Formation Assays—Huh-7.5 cells were trypsinized 1 day
before transfection. Cells (2  106) were washed once with DMEM
lacking serum and suspended in 0.9 ml of the same medium. RNA-
liposome complexes were prepared using the TransMessenger reagent
from Qiagen. Cells and and RNA-liposome complexes were mixed and
incubated at 37 °C for 1 h. After incubation, cells were pelleted by cen-
trifugation (525 g) for 4min and suspended inDMEMcontaining 10%
fetal bovine serum. Cells were plated in 100-mm Petri dishes in the
absence of feeder cells at the following densities: 1  106, 2  105, and
2  104. After 2 days of recovery, cells were treated with 0.5 mg/ml
G418, and selection was continued for 3 weeks with medium changes
every 4 days. Cells were fixed and stained using crystal violet. At least
three independent experiments were performed for each transfection.
Western Analysis—Huh-7.5 cells were transiently transfected with
HCV RNA using TransMessenger Lipofectin Reagent (Qiagen) accord-
ing to the manufacturer’s instructions. Cells were lysed at 4 h post-
transfection in SDS-PAGE denaturing sample buffer. Lysate from 5 
105 cells from each transfection was run on 10% SDS gel. Proteins were
transferred from gel to polyvinylidene difluoride membrane using a
Bio-Rad electrophoretic transfer cell at 100 V for 1 h at 4 °C in transfer
buffer (25 mM Tris, 192 mM glycine). Membranes were blocked in 5%
dry milk/TBST (20 mM Tris/Cl, pH 7.5, 137 mM NaCl, 0.1% Tween 20)
for 1 h. Blockedmembranes were exposed to rabbit polyclonal anti-NS3
in 5% bovine serum albumin/TBST for 90 min and then exposed to
horseradish peroxidase-conjugated goat anti-rabbit IgG (PerkinElmer
Life Sciences) in 5% dry milk/TBST for 1 h. Chemiluminescent detec-
tion was done by an ECLWestern blotting analysis system (Amersham
Biosciences).
Nucleic Acid Binding Assays—NS3h was incubated with 500 pM
5-fluorescein labeled rU20 (Integrated DNA Technologies) in 50 mM
MOPS (pH 7.0), 10 mM NaCl, 50 M EDTA, 0.1 mg/ml bovine serum
albumin for 5 min at 37 °C. Binding was measured as a function of
fluorescence polarization using a Beacon fluorescence polarization
instrument. Data were fit to a hyperbola using Kaleidagraph software.
ATPase Assays—NS3h was incubated with 5 mM ATP in 50 mM
HEPES (pH 7.5), 0.5 mM EDTA, 10 mMMgCl2, 10 mMNaCl, 0.1 mg/ml
bovine serum albumin, 4 mM phosphoenolpyruvate, 10 units/ml pyru-
vate kinase/lactate dehydrogenase, and 0.7 mg/ml NADH. Absorbance
of NADH at 380 nmwasmeasured at 1-s intervals for a period of 30 s in
the presence of the indicated concentrations of poly(U). Hydrolysis
rates were calculated using an extinction coefficient of 1,210 M1 cm1
for NADH. Data were fit to a hyperbola using Kaleidagraph software.
DNAUnwinding Assays—Unwinding assays were carried out using a
Quench-Flow apparatus (RQF-3, KinTek Instruments, Austin, TX) and
a two-step mixing protocol (32). The temperature was held constant at
37 °Cwith a circulating water bath. Reactions were carried out in 25mM
MOPS (pH 7.0), 10mMNaCl, 0.1mMEDTA, 2mM -mercaptoethanol,
and 0.1 mg/ml bovine serum albumin; all concentrations are postmix-
ing. NS3h (500 nM) was mixed with 2 nM DNA substrate (30-base pair
duplex with 3 T15 overhang; the longer strand was radiolabeled with
32P) for 10 s before adding 5 mM ATP, 10 mM MgCl2, 60 nM annealing
trap (complementary to the displaced strand), and 100 M poly(dT)
protein trap. The reaction was quenched after 0.1–15 s by ejection into
a tube containing 200 mM EDTA, 0.7% SDS. Double- and single-
stranded DNA were resolved on a native 20% polyacrylamide gel,
detected using a PhosphorImager (Amersham Biosciences), and quan-
tified using ImageQuant software. Bench top experiments were used to
determine the amplitude of product formation under single turnover
conditions. NS3h was added to substrate (2 nM), followed by a 10-s
incubation. ATP (5 mM), MgCl2 (10 mM), and a protein trap (poly(dT),
100 M) were added to initiate the unwinding reaction. The reaction
was stopped after 10 s by adding 200 mM EDTA. Data were fit to Equa-
tion 1, using Kaleidagraph (Synergy Software, Reading, PA). This equa-
tion describes a five-step mechanism for DNA unwinding that is neces-
sary to fit the substantial lag phase associated with unwinding of the
substrate (32, 36, 37).
Y  A(11  kobs t  1/2kobs t
2  1/6kobs t
3
 1/24kobs t
4ekobs t) (Eq. 1)
RESULTS
Crystallization and Structural Analysis of NS3hBound to (dU)16—Crys-
tals of NS3h in the presence of (dU)16 oligonucleotide belonged to space
group P212121 with unit cell dimensions a 108.3 Å, b 109.8 Å, and c
183.4 Å (Table 1). We determined the structure by theMRmethod, using
1A1V.pdb (23) as an initial model, in which its (dU)8 fragment was manu-
ally removed prior to the rotational function search. We identified three
helicasemolecules (chains A, B, andC in Fig. 1) per asymmetric unit in our
structure, with two helicase molecules bound to a single (dU)16 molecule.
The final atomic model shows no major unfavorable steric interactions
between the helicasemolecules, and the crystal packing shows no conflicts
between the proteinmolecules in adjacent asymmetric units.We found no
apparent noncrystallographic symmetric operations among the three
monomers in this helicase model, nor did we observe any dramatic differ-
ences among themonomers.All three helicasemolecules retain the basicY
TABLE 1
Data collection and refinement statistics
Parameter Value
Data collection












Resolution (Å) 30 to 3.3
No. of reflectionsb 27,936 (1,673)
Rb,c (%) 24.8 (27.4)
Average B-factors (Å) 34.25
r.m.s. deviation bond lengths (Å) 0.010
r.m.s. deviation bond angles (degrees) 1.495
a Rsym  I  I	/I, where I represents intensity.
b Value for Rfree set containing 5% of randomly chosen reflections.
c r  Fo  Fc/Fo.
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shape characteristic of previously reported structures, with minor confor-
mational differences at the surface loop regions.
Chains A and B of the complex are bound to a 13-nucleotide span of
one (dU)16 molecule, with chain B rotated 90° relative to chain A. The
binding mode of both chains is consistent with that of the 1A1V struc-
ture, with the binding cleft at the interface of domains 1 and 2 with
domain 3 in each protein molecule. Chain C appears to be independent
of the dimer-oligonucleotide complex. The nucleic acid binding cleft of
chainC faces away from the dimer structure and is occupied by a second
oligonucleotide molecule. Chain C does not have any evident structural
or mechanistic relationship with the other two protein molecules, and
there appear to be no suitable contacts between chains B and C to
indicate a functional interaction between these two molecules.
To determine the degree of similarity between chains A and B, we
superimposed the two using domain 1 (the NTPase domain) as an
anchor (the backbone r.m.s. deviation for residues 190–324 was 0.7 Å).
We observed only minor conformational differences between the two
chains in each of the three domains (Fig. 2). However, it appears that the
relative orientation of domain 2 with respect to the anchored domain 1
is slightly different between chains A and B with a small but detectable
tilting angle, resulting in a slight widening of the nucleic acid binding
groove in chain B. This flexibility of domain 2 relative to domain 1 is
consistent with the ratchet mechanism for nucleic acid translocation
proposed byKim et al. (23). Domain 3 displays a small degree of rotation
between chains A and B but is otherwise similar.
To assess the relationship of the apparent dimer structure to that of
the monomeric NS3-oligonucleotide complex reported by Kim et al.
(23), we independently aligned each of the two monomer structures
(chains A and B) with the 1A1V structure (data not shown). Both chains
of the dimer structure alignwell with 1A1V,with chainAbeing a slightly
better fit than chain B (overall r.m.s. deviation0.9 and1.3 Å, respec-
tively). Aside from the slight widening of the groove between domains 2
and 3 in chain B of our structure, no significant structural differences
exist between the structure of 1A1V and the structures of our A and B
chains.
In the dimer structure, the oligonucleotide is bound to each NS3h
molecule within the groove formed at the interface of domains 1 and 2
with domain 3 (Fig. 1). The DNA interactions with chain A are virtually
identical to those observed in the 1A1V structure. In the region between
chains A and B, the DNA appears to be bent by nearly 90 degrees. It is
possible that this bend is stabilized by the apparent base stacking
between nucleotides dU8 and dU10. However, the electron density in
this region is weak, and although structure validation by WHAT_
CHECK (38) suggested that the bent conformation of theDNA is allow-
able according to Parkinson (39), we accept the possibility that the bend
may indeed exist in another conformation. Comparisons of the 3 bind-
ing regions in both chains A and B to 1A1V exhibited high similarity in
nucleotide binding, suggesting that the binding mode of the oligonu-
cleotide between chains A and B is likely to exist as presented. The
overall DNAbindingmodewith respect to chain B is similar to that with
respect to chainA (Fig. 3,A andB). However, due to the displacement of
domain 2 in chain B, domains 2 and 3 are farther apart than in chain A.
In turn, the binding groove of chain B is slightly wider and causes the
oligonucleotide to tilt toward domain 2, allowing domain 1 and the
oligonucleotide backbone to retain the same interactions observed in
chain A. The domain displacement, however, does not dramatically
alter the interactions of oligonucleotide with domains 1 and 3. For
example, the Trp501 side chain retains its ring-to-ring stacking position,
and Thr269 remains in position to allow hydrogen bonding with the
phosphate backbone of the DNA at dU11 (Fig. 3, A and B). The DNA
fragment in chain B is pushed slightly out of the binding groove and
shifted away from the-helical domain. As a result, the electron density
for this fragment is less clear than that in chain A.
There are numerous close interactions between chains A and B
involving multiple sets of amino acid residues, including His545–Ala553
and Cys584–Thr591 of chain B, and Thr435–Gln453, Thr477–Ser488, and
Val524–Gln536 of chain A (Fig. 4A). In addition, Thr450 of chain A and
Gln549 of chain B appear to be in position to allow hydrogen bond
formation between the twomonomers at the dimeric interface (Fig. 4B).
To assess the strength of interaction between chains A and B, we calcu-
lated the extent of buried surface area (SAB) at the interaction site using
WHATIF molecular modeling software (40). This value is defined as
SAB  AA 
 AB  AAB, where A is the total surface area of the folded
polypeptide molecule. The surface areas of chains A and B are 5883 and
5839 Å2, respectively. The total surface area calculated for the dimer is
11,279 Å2, leaving a difference of 443 Å2 buried at the interface. This
area is not sufficient to support independent dimer formation in the
absence of nucleic acid, which is consistent with the observed mono-
meric behavior of NS3h in size exclusion chromatography.6
6 K. D. Raney and Y. Chen, unpublished observations.
FIGURE 1. X-ray crystal structure of NS3h bound to a 16-mer poly(dU) substrate.
Three molecules of NS3h are found in the asymmetric unit, and two of the helicase
monomers, chain A (red) and chain B (blue), are bound to a single DNA substrate mole-
cule (aqua). The third molecule of the asymmetric unit (chain C, shown in green) is bound
to a separate strand of nucleic acid. The DNA passes across the face of chain A, emerging
between domains 2 and 3, where it enters the binding site of chain B.
FIGURE 2. Superposition of chains A (red) and B (blue) that comprise the NS3h dimer
structure. The two structures were superimposed using domain 1 (1) as an anchor and
yielded an r.m.s. deviation of 0.7 Å. Domain 2 of chain B (2) is tilted slightly relative to its
position in chain A.
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Biological Analysis of Surface Residues—To assess the importance of
the protein-protein interface region observed in the crystal structure,
we performed a mutational analysis involving two clusters of residues
(Asp543/His545/Gln549 and Arg587/Leu588/Lys589/Thr591) in domain 3
(Fig. 4). These residues are situated at the interface of the two NS3h
molecules and appear to be of particular importance in the protein-
protein interaction. We did not introduce mutations at the domain 2
interface site because of its proximity to the conserved helicase motifs.
Amino acid residues 543–545 were deleted (543–545), and two sets of
substitution mutations (D543K/H545D/Q549A and R587D/L588D/
K589D/T591D) were introduced independently into the HCV-neo-
I377/NS3–3-untranslated region replicon (14) containing an S1179I
adaptive mutation (12).
We transfected Huh-7.5 human hepatoma cells with mutant HCV
RNA and monitored the cells for replication-dependent growth. Cells
transfected with S1179I HCV RNA formed large, densely spaced colo-
nies after 2–3 weeks of growth (Fig. 5A). Cells transfected with the
mutant HCV RNA showed significantly reduced colony formation,
indicating that the targetedNS3 surface region is important for efficient
viral replication. The 543–545 and D543K/H545D/Q549A (NS3h
KDA) mutants were of particular interest, since they supported little or
no cell growth (Fig. 5, C and D). The R587D/L588D/K589D/T591D
mutation (NS3h DDDD), at a different site within the protein interface
than the 543–545 and NS3h KDA mutations, had a visible but less
dramatic effect on growth (Fig. 5E).
We performed a Western analysis with NS3 antibody on transfected
cell lysates in order to determine whether NS3 protein expression was
affected by any of the mutations (Fig. 6). The 543–545 mutant NS3
protein was present at significantly lower concentration than observed
in S1179I-transfected cells. However, no impairment of translation was
observed for either of the two substitution mutants. Quantitative com-
parison with purified NS3h standards indicated that these similar
expression levels were not an artifact of saturating assay conditions
(supplemental Fig. 1).
Biochemical Analysis of NS3h Mutants—In order to determine the
effects of the surface mutations on the biochemical activities of NS3h,
we overexpressed and purified NS3h KDA and NS3h DDDD in a pro-
karyotic expression system and compared the binding and enzymatic
activities of the mutant NS3h proteins with those of wild type. We
measured theRNAbinding affinity of themutant andwild type enzymes
FIGURE 3. A, the terminal region of the oligonucleotide (aqua) interacts with NS3h chain A (red) via a hydrogen bond between Thr269 (T269) and the phosphate backbone and ring
stacking between nucleotide dU1 and Trp
501 (W501; green). B, at the point where the oligonucleotide (aqua) enters the binding groove of chain B (blue), interactions identical to those
with chain A are observed (Trp501-dU ring stacking and Thr269-phosphate hydrogen bond formation).
FIGURE 4. Depiction of the dimer structure involving chains A (red) and B (blue)
illustrating the residues involved in the protein-protein interaction. A, five sets of
residues are identified at the dimer interface, including His545–Ala553 (purple) and
Cys584–Thr591 (orange) of chain B and Thr435–Gln453 (yellow), Thr477–Ser488 (green), and
Val524–Gln536 (cyan) of chain A. B, a close-up view of the dimer interface. A pair of hydro-
gen bonding partners, Thr450 of chain A and Gln549 of chain B, is highlighted.
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using a fluorescein-labeled oligonucleotide substrate (Fig. 7). The NS3h
KDA mutation did not impair binding to RNA, but the NS3h DDDD
mutation severely reduced binding affinity as measured by fluorescence
polarization. Poly(U)-stimulatedATP hydrolysis of themutant andwild
type enzymes was measured, and no significant differences were
observed between the activities of the wild type and NS3h KDAmutant
(Fig. 8). The activity of the NS3h DDDDmutant was severely impaired,
probably as a consequence of its reduced nucleic acid binding affinity.
Unwinding of nucleic acid wasmeasured by using a standard helicase
assay (Fig. 9A) with a substrate (45/30-mer) containing 30 base pairs
with a 15-nucleotide 3 single-stranded overhang. Very little unwinding
of an RNA substrate by NS3h was observed (Fig. 9B), consistent with a
recent report describing the lack of RNA unwinding activity of NS3h
(27), so unwinding rates were determined using a DNA substrate (30).
Under single turnover conditions, NS3h exhibited a lag phase similar to
that observed previously for a substrate of similar length (Fig. 10) (32).
The lag phase represents multiple steps that are believed to occur prior
to complete unwinding of the duplex (36, 37, 41). However, NS3h KDA
unwound the substrate with a similar lag phase as the wild type enzyme
but somewhat lower amplitude (Fig. 10). Very little unwinding was
observedwithNS3hDDDD, consistent with the poor binding to nucleic
acid. The amplitude for unwinding reflects the degree of processivity of
the enzyme (30, 32, 42); therefore, NS3h KDA has slightly lower proces-
sivity than NS3h. Increasing the enzyme concentration resulted in
higher amplitudes for each enzyme. We previously reported that bind-
ing of multiple full-length NS3molecules to this substrate increases the
amplitude for unwinding (30). The results here with NS3h are consist-
ent with the observation for full-length NS3.
DISCUSSION
We describe here the first x-ray crystal structure of NS3 helicase
bound to a DNAmolecule of sufficient length to accommodate binding
of twomolecules of enzyme. Our structure shows a nucleic acid binding
site for each monomer that is consistent with a published crystal struc-
ture of a single monomer bound to a shorter DNA molecule (23). In
each case, theDNAbinds to a cleft between domains 1 and 2 on one side
and domain 3 on the other. DNA binding is not sequence-specific, with
the majority of protein-DNA contacts involving the phosphate back-
bone. The structure also reveals a protein-protein interface between
two DNA-bound helicase monomers. The protein-protein contacts are
mostly hydrophobic and involve domain 2 of one subunit (chain A) and
domain 3 of the second subunit (chain B). The two nucleic acid binding
sites of the dimer are therefore aligned in such a way as to force a
significant bend in the bound DNA that appears to induce a base stack-
ing motif in the oligonucleotide.
The structure and function of HCV helicase have been investigated
extensively. Important amino acid sequence motifs that play critical
roles in biochemical function have been identified in both domains 1
FIGURE 5. Growth of Huh-7 cells after transfection with wild type and mutant forms
of the HCV replicon. Colony formation of Huh-7 cells was monitored over a period of 3
weeks following transfection by HCV replicon RNA. Colonies were stained with 0.1%
crystal violet. Representative plate images for each transfection are as follows. A, S1179I
RNA; B, blank transfection (no RNA); C, D543K/H545D/Q549A mutant RNA; D, 543–545
mutant RNA; E, R587D/L588D/K589D/T591D mutant RNA. Colony-forming units per
microgram of RNA for each experiment were as follows: 15,560  940, 2,720  440, and
7,760  1,072 for the S1179I RNA, D543K/H545D/Q549A mutant RNA, and R587D/
L588D/K589D/T591D mutant RNA, respectively. No colonies were observed for the blank
treatment or for the 543–545 mutant RNA.
FIGURE 6. Western analysis of HCV-transfected Huh-7.5 cell lysates. 5  105 cells
from each lysate were loaded on a 10% polyacrylamide gel. The gel was blotted onto a
polyvinylidene difluoride membrane, and the blot was incubated with rabbit anti-NS3.
Primary antibody binding was detected by chemiluminescence with horseradish perox-
idase-conjugated anti-rabbit IgG. The lane marked NS3 shows purified NS3. The lane
marked C shows the control transfection with no HCV RNA. WT, wild type.
FIGURE 7. Binding of mutant NS3h to fluorescein-labeled U20 RNA. Nucleic acid bind-
ing was determined by measuring fluorescence polarization following incubation of
protein and nucleic acid at 37 °C. Data were fit to a hyperbola using Kaleidagraph soft-
ware. A, NS3h wild type (F) bound to RNA with a KD of 47  5 nM, and NS3h KDA (E)
bound to RNA with a KD of 38  4 nM. NS3h DDDD (f) did not bind with high enough
affinity to determine a binding constant under these conditions.
FIGURE 8. ATPase activity of mutant NS3h (50 nM) was measured as a function of
nucleic acid concentration in a coupled spectrophotometric assay. Data represent
the average of three independent experiments and were fit to a hyperbola using Kalei-
dagraph software. Specific activity of NS3h wild type (F) and NS3h KDA (E) were com-
parable at 126 and 108 s1, respectively, in the presence of saturating poly(U). Specific
activity of NS3h DDDD (f) was lower at 70 s1. The concentration of nucleic acid (Kact)
required to reach one-half Vmax was 0.89, 0.68, and 5.84 M for NS3h wild type, NS3h KDA,
and NS3h DDDD, respectively.
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and 2. The function of domain 3 has been less well characterized.
Domain 3 of superfamily II helicases is less conserved compared with
domains 1 and 2, and there is no apparent homology in domain 3 among
the different helicase superfamilies (43). However, the sequence of
domain 3 is highly conserved among HCV isolates (supplemental Fig.
2). In the structure reported here, surface regions on domain 3 appear to
interact with domain 2 of the second molecule. Biological studies dem-
onstrate that mutations in these surface regions interfere with viral rep-
lication in cell culture. Although it remains difficult to speculate as to its
precise function, domain 3may play a role inmediating the formation of
protein-protein complexes between NS3 monomers or between NS3
and other proteins in addition to its critical role in substrate binding.
Severalmodels for helicase function ofNS3have been proposed. Each
mechanism is driven by binding and hydrolysis of ATP, which is
thought to drive the enzyme through multiple conformational states.
One model is the proposed inchworm-type mechanism in which the
helicase repeatedly releases and rebinds a single strand of the nucleic
acid substrate. Such a mechanism has been described for PcrA helicase
(44) as well as for NS3h (45). The structure reported here shows two
interacting monomers bound in series to the same DNA strand. Heli-
cases that dimerize have been studied extensively by the Lohman labo-
ratory, and a dimeric inchworm model has been suggested for E. coli
Rep helicase (46). The alignment of the NS3h molecules along nucleic
acid would favor some form of inchworm mechanism rather than a
hand-over-hand mechanism, because the protein interface does not
appear to be sufficient to maintain protein-protien interactions in the
absence of nucleic acid binding. It is interesting that the dimeric struc-
ture reported here does not appear to impede flexible motions between
domains 1 and 2 of the enzyme that are proposed to play a role in the
inchworm mechanism (23). A model for NS3h activity involving
Brownian motion was recently proposed based on the observation of
two states of DNA binding (strong affinity and weak affinity) in the
presence or absence of ATP (47). This “Brownian motor” model does
not require protein-protein interactions for helicase activity. However,
the model suggests that when multiple NS3h molecules bind to the
same substrate molecule, the adjacent enzymes may enhance the net
activity by reducing the possibility for backwards sliding of the helicase
during the unwinding cycle. Our own work is consistent with this gen-
eral concept, in whichmultiple molecules of helicase bound to the same
substrate enhance unwinding activity (30).
Recently, a model for unwinding by full-length NS3 was proposed
that suggests a dimeric form of the enzyme based in part on an 18-bp
step size determined by high resolution kinetic measurements (25). The
structure reported here is consistent with the proposed dimeric form of
the enzyme. However, unwinding data for the full-length form of NS3
indicate that a larger oligomer or substrate saturation may be required
for optimal activity (30). NS3 is reportedly less processive in the absence
of its co-factor,NS4A (42), so final conclusions regarding the oligomeric
form required for optimal unwinding await detailed kinetic and bio-
physical studies of the NS3-4A complex. NS3h exhibits relatively weak
protein-protein interactions, whereas full-length NS3 appears to inter-
act with itself more strongly,7 which may account for some of the dif-
ferences in activities observed between the two forms of the enzyme. For
example, NS3h unwound only 17% of the 45/30-mer (Fig. 10), whereas
full-length NS3 unwound greater than 80% of the same substrate under
the same conditions (30). Therefore,NS3h exhibits lower processivity in
DNA unwinding than the full-length protein, which may reflect the
relative strength of protein-protein interactions.
The mutations at the interface of the putative NS3h dimer were
7 K. D. Raney and Y. Chen, manuscript in preparation.
FIGURE 10. A two-step mixing technique was used to measure single-turnover
unwinding in the presence of excess NS3h. A, NS3h (1 M) or one of the mutant
enzymes was rapidly mixed with substrate followed by a 10-s incubation. A second, rapid
mixing step followed, in which ATP, Mg2
, and protein trap (poly(dT)) were added. The
quench solution was placed in the receiving vial. Single-stranded DNA (ssDNA) was sep-
arated from double-stranded DNA by native polyacrylamide electrophoresis, and the
fractions were quantitified by using ImageQuant software. Data were fit according to
Equation 1, resulting in unwinding rates of 3.1  0.1 s1, 3.7  0.1 s1, and 4.5  0.9 s1
for NS3h (F), NS3h KDA (), and NS3h DDDD (f), respectively. B, unwinding amplitude
versus concentration of NS3h and NS3h mutant enzymes. Bench top experiments were
used to determine the amplitude of product formation under single turnover conditions.
The amplitudes for NS3h (F), NS3h KDA (), and NS3h DDDD (f) were plotted as a
function of enzyme concentration. The error bars represent S.D. of triplicate
measurements.
FIGURE 9. A, the assay for measuring helicase unwinding activity is depicted. A partial
duplex substrate containing 30 bp and 15 nucleotides of single-stranded overhang (45/
30-mer) was incubated with NS3h in the presence of ATP and Mg2
, leading to unwind-
ing of the duplex. B, comparison of unwinding of DNA and RNA substrates by NS3h
(representative gels). Otherwise identical 250 nM duplexed DNA and RNA substrates
were incubated with 100 nM NS3h. Reactions were initiated by the addition of 5 mM ATP
and 10 mM MgCl2 and quenched by the addition of 200 mM EDTA, 0.7% SDS. ssDNA and
ssRNA, single-stranded DNA and RNA, respectively; dsDNA and dsRNA, double-stranded
DNA and RNA, respectively.
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designed to disrupt protein-protein interactions. These mutations
would not be expected to disrupt the biochemical activities of mono-
meric NS3h. Indeed, NS3h KDA exhibits activities that mirror the wild-
type enzyme in terms of nucleic acid binding and ATPase activity. The
only biochemical activity of NS3h KDA that is reduced is processivity,
which may reflect reduced protein-protein interactions. However, the
reduction in amplitude for unwinding under single turnover conditions
is only 2-fold, which would seem unlikely to be responsible for the
dramatic reduction in HCV replicative capacity exhibited with the
NS3h KDAmutations. Hence, the biochemical results are not sufficient
to explain the biological results. The results with NS3h DDDD further
emphasize this point. NS3h DDDD has much lower affinity for nucleic
acid than wild-type NS3h, resulting in little product formation under
single turnover unwinding conditions. However, the replicative capac-
ity of the HCV replicon containing the DDDDmutation is greater than
theHCV replicon containing the KDAmutation. Thus, the biochemical
activities that are typically measured of NS3h do not appear to reflect all
of the biological activities of this enzyme.
It remains a strong possibility that the protein surface implicated in for-
mationof adimerichelicase in vitromediates additional interactions in vivo
that are required for formation of amultiprotein viral replication complex.
For example, this protein surfacemight bind to theNS5BRNApolymerase
to form part of the HCV replication machinery. NS5B has been shown to
interact with NS3 (48). Several reports support the idea that HCV replica-
tion takes place at specific membrane-associated sites (17, 49, 50). NS3,
NS5B, and other nonstructural viral proteins co-localize in replicon-trans-
fected cellswithin the endoplasmic reticulum(17).A recent report suggests
that lipid rafts may support viral replication (18). Insertion of active viral
transcription complexes into cellular membranes would presumably
require some sort of coordinatedmembrane-targeting and assembly proc-
ess. It is reasonable to hypothesize that this assembly process requires spe-
cific protein-protein and protein-DNA interactions that are not necessary
for in vitro enzyme activity. The crystal structure described here may rep-
resent a protein complex required for some function of NS3 not directly
related to unwinding. For example, the helicase dimer (or larger oligomer)
maysequester single-strandednucleic acids thathavealreadybeenactedon
by the HCV replication machinery or may play a role in formation of viral
RNA secondary structures required for initiation of transcription or trans-
lation. A recent report suggests that HCVRNA is an integral part of a viral
nucleoprotein replication complex (18). The protein-protein interaction
suggested by the crystal structure could be a subunit of such a complex.
By solving the x-ray crystal structure of twomolecules ofNS3 helicase
bound to the same oligonucleotide, we have identified a region on the
surface of the protein that is required for efficient viral replication. The
amino acid residues in this region are highly conserved among different
HCV isolates. The surface region appears to be capable of mediating
protein-protein interactions but does not appear to be essential in the
nucleic acid binding or known enzymatic activities of NS3h. These data
illustrate thatNS3 has additional biochemical activities and/ormediates
protein-protein interactions in vivo through domain 3 that are not
reflected in standard helicase assays.
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Supplemental Figure 1
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Supplemental Figure 1. Quantitative western analysis of HCV-trasfected Huh-7.5
cell lysates.  A ten-fold mass range of purified NS3 protein (lanes A-C) was used to
establish sensitivity limits of the assay.  Amounts of NS3 obtained from lysates (lanes
D-F) fall within the sensitivity range established by the standards.  Density of each
protein band was determined using Scion Image (Scion Corp.) and is given below
each band in arbitrary units.
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Supplemental Figure 2 
HCV-1b 483 sgmfdssvlcecydagcawyeltpaetsvrlraylntpglpvcqdhlefw 
HCV-1a 483 sgmfdssvlcecydagcawyeltpaettvrlraymntpglpvcqdhlefw 
HCV-2a 483 sgmfdsvvlcecydagaawyeltpaettvrlrayfntpglpvcqdhlefw 
HCV-2b 483 sgmfdsvvlcecydagaawyeltpaettvrlrayfntpglpvcqdhlefw 
HCV-3b 483 sgmfdsvvlcecydagcswydlqpaettvrlraylstpglpvcqdhldfw 
HCV-4a 483 sgmfdtaelcecydagcawyeltpaetttrlkayfdtpglpvcqdhlefw 
HCV-5a 483 sgifdsvvlcecydagcawydltpaettvrlraylntpglpvcqehlefw 
HCV-6a 483 sgmfdtvvlceaydtgcawyeltpsettvrlraymntpglpvcqdhlefw 
KDA/DDDD 483 sgmfdssvlcecydagcawyeltpaetsvrlraylntpglpvcqdhlefw 
HCV-1b 533 esvftglthidahflsqtkqagdnfpylvayqatvcaraqapppswdqmw 
HCV-1a 533 egvftglthidahflsqtkqsgenfpylvayqatvcaraqapppswdqmw 
HCV-2a 533 eavftglthidahflsqtkqsgenfayltayqatvcarakapppswdvmw 
HCV-2b 533 eavftglthidahflsqtkqggenfayltayqatvcarakapppswdvmw 
HCV-3b 533 ervftglthidahflsqakqqglnfaylvayqatvcarakasppcwdemw 
HCV-4a 533 esvftglthidghflsqtkqsgenfpylvayqatvsakvwlappswdtmw 
HCV-5a 533 egvftgltnidahmlsqakqggenfpylvayqatvcvrakapppswdtmw 
HCV-6a 533 egvftglthidahflshtkqagenfaylvayqatvcarakapppswdmmw 
KDA/DDDD 533 esvftglthikadflsatkqagdnfpylvayqatvcaraqapppswdqmw 
HCV-1b 583 kclirlkptlhgptpllyrlgavqnevilthpitkyimacmsadlevvt 
HCV-1a 583 kclirlkptlhgptpllyrlgavqnevtlthpitkyimtcmsadlevvt 
HCV-2a 583 kcltrlkptlvgptpllyrlgsvtnevtlthpvtkyiatcmqadlevmt 
HCV-2b 583 kcltrlkptltgptpllyrlgavtnevtlthpvtkyiatcmqadleimt 
HCV-3b 583 kclirlkptlqgptpllyrlgaiqndicmthpitkyimacmsadlevtt 
HCV-4a 583 kclirlkptlhgptpllyrlgsvqnevvlthpitkyimacmsadlevvt 
HCV-5a 583 kcmiclkptltgptpllyrlgavqneitlthpitkyimacmsadlevit 
HCV-6a 583 kclirlkptltgptpllyrlgavqngvitthpitkyimtcmsadlevit 
KDA/DDDD 583 kclidddpdlhgptpllyrlgavqnevilthpitkyimacmsadlevvt 
Supplemental Figure 2.  Sequence conservation in domain 3 of NS3 among isolates 
from different strains of HCV.  The HCV-1b sequence shown here is that of the 
crystallized protein.  Absolutely conserved residues are highlighted in yellow.  Mutation 
sites are highlighted in green, and the resulting substitutions are highlighted in blue. 
